MMP9 and renal fibrosis: EVs released by engineering MSCs mediate the transfer of miRNA-let7 to diseased kidneys and alleviate renal fibrosis by inhibiting fibrosis genes COL-4, MMP-9, α-smooth muscle actin (α-SMA), TGF-β 1, and their receptors [228].